Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Patients Receiving Myelosuppressive Treatment Regimens Requiring Platelet Transfusion Support.

NCT00037791 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00037791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Patients Receiving Myelosuppressive Treatment Regimens Requiring Platelet Transfusion Support.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1999
Completion date
September 30, 2002
Enrollment
180
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, malignant, multiple myeloma, neoplasms, thrombocytopenia